References
- Howson CP, Kinney MV, McDougall L, et al. Born too soon: preterm birth matters. Reprod Health. 2013;10(Suppl. 1):S1.
- Behrman RE, Butler AS, editors. Medicine I of preterm birth: causes, consequences, and prevention [Internet]. Washington (DC): The National Academies Press; 2007. Available from: https://www.nap.edu/catalog/11622/preterm-birth-causes-consequences-and-prevention
- Johnston CA, Moreno JP. Pregnancy: a time of increased focus on health. Am J Lifestyle Med. 2014;8(2):93–96.
- Watson HA, Carter J, Seed PT, et al. The QUiPP App: a safe alternative to a treat-all strategy for threatened preterm labor. Ultrasound Obstet Gynecol. 2017;50(3):342–346.
- Carter J, Seed PT, Watson HA, et al. Development and validation of predictive models for QUiPP App v.2: tool for predicting preterm birth in women with symptoms of threatened preterm labor. Ultrasound Obstet Gynecol. 2020;55(3):357–367.
- Wing DA, Haeri S, Silber AC, et al. Placental alpha microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol. 2017;130(6):1183–1191.
- Nikolova T, Uotila J, Nikolova N, et al. Prediction of spontaneous preterm delivery in women presenting with premature labor: a comparison of placenta alpha microglobulin-1, phosphorylated insulin-like growth factor binding protein-1, and cervical length. Am J Obstet Gynecol. 2018;219(6):610.e1–610.e9.
- Melchor JC, Khalil A, Wing D, et al. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;52(4):442–451.
- Di Renzo GC, Roura LC, Facchinetti F, et al. Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine. J Matern Fetal Neonatal Med. 2017;30(17):2011–2030.
- Nikolova T, Bayev O, Nikolova N, et al. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict. J Perinat Med. 2013;1:5–9.
- Nikolova T, Bayev O, Nikolova N, et al. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 2015;43:1–8.
- Melchor JC, Navas H, Marcos M, et al. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Ultrasound Obstet Gynecol. 2018;51(5):644–649.
- Pirjani R, Moini A, Almasi-Hashiani A, et al. Placental alpha microglobulin-1 (PartoSure) test for the prediction of preterm birth: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2019;1–13. doi:https://doi.org/10.1080/14767058.2019.1685962
- Kashanian, Maryam et al. “Evaluation of placental alpha microglobulin-1(PAMG1) accuracy for prediction of preterm delivery in women with the symptoms of spontaneous preterm labor; a comparison with cervical length and number of contractions.” J Matern Fetal Neonatal Med. 2020;1–7. doi:https://doi.org/10.1080/14767058.2020.1728246
- Çekmez Yasemin, Kıran Gürkan, Haberal Esra Tuştaş, Dizdar Merve. Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth. BMC Pregnancy Childbirth. 2017;17(1):246. doi:https://doi.org/10.1186/s12884-017-1427-0.